Menu

Back to Medication Guide

Tofacitinib

Generic Name: Tofacitinib

Brand Names: Xeljanz

Tofacitinib is a JAK inhibitor for rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and other conditions.

RheumatologicGastrointestinalJAK Inhibitor

What It's Used For

Side Effects

Common side effects:

  • Upper respiratory infections
  • Headache
  • Diarrhea
  • Nasopharyngitis

Serious side effects (boxed warnings):

  • Serious infections
  • Malignancy
  • Thrombosis (PE, DVT)
  • Major cardiovascular events
  • Death

Additional Information

What is Tofacitinib?

Tofacitinib is an oral JAK inhibitor that blocks JAK1 and JAK3 signaling pathways.

Boxed Warnings

FDA boxed warnings include increased risks of:

  • Serious infections
  • Malignancy (especially lymphoma)
  • Blood clots
  • Heart attacks and strokes
  • Death

Use Restrictions

Due to safety concerns, reserved for patients who have failed TNF inhibitors.

For details, see MedlinePlus.

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.

Loading questions...

Ask Dr. Zimmer

Have questions about Tofacitinib? Get expert answers from Dr. Zimmer.

Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.

Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.